Nogra Pharma

Nogra Pharma Limited is a private pharmaceutical development company established in 2005, with its headquarters located in Dublin, Ireland. The company already has a successful product on the market for the treatment of ulcerative colitis, sold as Lialda in the United States and Mezavant in Europe and other regions, and marketed in collaboration with Shire.Nogra focuses on the early-stage development of products targeting the gastrointestinal area, specifically aiming to alleviate inflammatory symptoms caused by autoimmune responses. Nogra has expressed great satisfaction with the trial results of its second product, which is focused on the treatment of Crohn's disease, and is delighted to have found a strong partner in Celgene to advance its product through continued trials and successful development for market launch.